This is the first randomized trial directly comparing pulse-modulated Holmium:YAG laser and thulium fiber laser treatment of kidney stones during ureteroscopy.
Aldosterone synthase inhibition is a promising mechanism in the management of resistant hypertension
The sBLA for NAI was submitted to the FDA in March 2025.
There have been no prospective studies comparing stent use vs nonuse after ureteroscopy for uncomplicated renal stones.
A panelist discusses how these comparative results could influence clinical decision-making by suggesting potentially different magnitudes of benefit between enzalutamide and darolutamide depending on disease…
EAU Podcast: At the 2025 American Urological Association Meeting in Las Vegas, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talked to Dr. Neal Shore…
Purpose:Postoperative prognostic tools allow for improved prediction of future recurrence risk, patient counseling, assessment of eligibility for adjuvant treatments, and appropriate follow-up surveillance. The purpose…
The study findings are the first report of the Hugo™ robotic-assisted surgery system used in the US.
Introduction:Urologists face challenges in obtaining public research funding, leading to increasing reliance on the industry for research support. This study aimed to examine the extent…
Introduction:This retrospective study furthers our understanding of risk factors associated with hemorrhage and intervention in renal angiomyolipomas (R-AMLs), particularly in larger tumors (≥4 cm) and…
The CISTO study is the only going prospective study comparing radical cystectomy vs bladder-sparing options for high-grade NMIBC.
